Pharmaceutical agent for treatment of withdrawal symptoms

US5385903A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Karin G. Steppuhn · Berlin, DE
• Karin Bressler · Berlin, DE
• Martin Gieseler · Berlin, DE
• David N. Stephens · Berlin, DE
• Lechoslaw Turski · Berlin, DE

Key dates

• Filing date: Jul 9, 1992
• Grant date: Jan 31, 1995
• Expiry date: Jul 9, 2012

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use of the non-NMDA receptor antagonists quisqualate or kainate antagonists or their physiologically compatible salts for treatment of withdrawal symptoms after drug abuse as well as the combination of the new pharmaceutical agents with NMDA antagonists are described.